_version_ 1785090992565649408
author Popat, Uday R.
Lontos, Konstantinos
Bassett, Roland
Kawedia, Jitesh
Valdez, Ben C.
Gulbis, Alison
Alousi, Amin M.
Al-Atrash, Gheath
Bashir, Qaiser
Hosing, Chitra M.
Im, Jin S.
Kebriaei, Partow
Khouri, Issa
Marin, David
Mehta, Rohtesh S.
Nieto, Yago
Oran, Betul
Olson, Amanda
Qazilbash, Muzaffar H.
Ramdial, Jeremy L.
Saini, Neeraj
Srour, Samer A.
Kadia, Tapan
Daver, Naval
Short, Nicholas
Rezvani, Katayoun
Shpall, Elizabeth J.
Champlin, Richard E.
Andersson, Borje S.
author_facet Popat, Uday R.
Lontos, Konstantinos
Bassett, Roland
Kawedia, Jitesh
Valdez, Ben C.
Gulbis, Alison
Alousi, Amin M.
Al-Atrash, Gheath
Bashir, Qaiser
Hosing, Chitra M.
Im, Jin S.
Kebriaei, Partow
Khouri, Issa
Marin, David
Mehta, Rohtesh S.
Nieto, Yago
Oran, Betul
Olson, Amanda
Qazilbash, Muzaffar H.
Ramdial, Jeremy L.
Saini, Neeraj
Srour, Samer A.
Kadia, Tapan
Daver, Naval
Short, Nicholas
Rezvani, Katayoun
Shpall, Elizabeth J.
Champlin, Richard E.
Andersson, Borje S.
author_sort Popat, Uday R.
collection PubMed
description
format Online
Article
Text
id pubmed-10430556
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104305562023-08-17 P1270: MYELOABLATIVE FRACTIONATED BUSULFAN-BASED CONDITIONING REGIMEN IN PATIENTS WITH AML AND MDS: RESULTS OF A RANDOMIZED CLINICAL TRIAL COMPARING 2 FRACTIONATION SCHEDULES Popat, Uday R. Lontos, Konstantinos Bassett, Roland Kawedia, Jitesh Valdez, Ben C. Gulbis, Alison Alousi, Amin M. Al-Atrash, Gheath Bashir, Qaiser Hosing, Chitra M. Im, Jin S. Kebriaei, Partow Khouri, Issa Marin, David Mehta, Rohtesh S. Nieto, Yago Oran, Betul Olson, Amanda Qazilbash, Muzaffar H. Ramdial, Jeremy L. Saini, Neeraj Srour, Samer A. Kadia, Tapan Daver, Naval Short, Nicholas Rezvani, Katayoun Shpall, Elizabeth J. Champlin, Richard E. Andersson, Borje S. Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430556/ http://dx.doi.org/10.1097/01.HS9.0000971968.06990.1e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Popat, Uday R.
Lontos, Konstantinos
Bassett, Roland
Kawedia, Jitesh
Valdez, Ben C.
Gulbis, Alison
Alousi, Amin M.
Al-Atrash, Gheath
Bashir, Qaiser
Hosing, Chitra M.
Im, Jin S.
Kebriaei, Partow
Khouri, Issa
Marin, David
Mehta, Rohtesh S.
Nieto, Yago
Oran, Betul
Olson, Amanda
Qazilbash, Muzaffar H.
Ramdial, Jeremy L.
Saini, Neeraj
Srour, Samer A.
Kadia, Tapan
Daver, Naval
Short, Nicholas
Rezvani, Katayoun
Shpall, Elizabeth J.
Champlin, Richard E.
Andersson, Borje S.
P1270: MYELOABLATIVE FRACTIONATED BUSULFAN-BASED CONDITIONING REGIMEN IN PATIENTS WITH AML AND MDS: RESULTS OF A RANDOMIZED CLINICAL TRIAL COMPARING 2 FRACTIONATION SCHEDULES
title P1270: MYELOABLATIVE FRACTIONATED BUSULFAN-BASED CONDITIONING REGIMEN IN PATIENTS WITH AML AND MDS: RESULTS OF A RANDOMIZED CLINICAL TRIAL COMPARING 2 FRACTIONATION SCHEDULES
title_full P1270: MYELOABLATIVE FRACTIONATED BUSULFAN-BASED CONDITIONING REGIMEN IN PATIENTS WITH AML AND MDS: RESULTS OF A RANDOMIZED CLINICAL TRIAL COMPARING 2 FRACTIONATION SCHEDULES
title_fullStr P1270: MYELOABLATIVE FRACTIONATED BUSULFAN-BASED CONDITIONING REGIMEN IN PATIENTS WITH AML AND MDS: RESULTS OF A RANDOMIZED CLINICAL TRIAL COMPARING 2 FRACTIONATION SCHEDULES
title_full_unstemmed P1270: MYELOABLATIVE FRACTIONATED BUSULFAN-BASED CONDITIONING REGIMEN IN PATIENTS WITH AML AND MDS: RESULTS OF A RANDOMIZED CLINICAL TRIAL COMPARING 2 FRACTIONATION SCHEDULES
title_short P1270: MYELOABLATIVE FRACTIONATED BUSULFAN-BASED CONDITIONING REGIMEN IN PATIENTS WITH AML AND MDS: RESULTS OF A RANDOMIZED CLINICAL TRIAL COMPARING 2 FRACTIONATION SCHEDULES
title_sort p1270: myeloablative fractionated busulfan-based conditioning regimen in patients with aml and mds: results of a randomized clinical trial comparing 2 fractionation schedules
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430556/
http://dx.doi.org/10.1097/01.HS9.0000971968.06990.1e
work_keys_str_mv AT popatudayr p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT lontoskonstantinos p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT bassettroland p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT kawediajitesh p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT valdezbenc p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT gulbisalison p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT alousiaminm p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT alatrashgheath p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT bashirqaiser p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT hosingchitram p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT imjins p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT kebriaeipartow p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT khouriissa p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT marindavid p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT mehtarohteshs p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT nietoyago p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT oranbetul p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT olsonamanda p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT qazilbashmuzaffarh p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT ramdialjeremyl p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT sainineeraj p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT sroursamera p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT kadiatapan p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT davernaval p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT shortnicholas p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT rezvanikatayoun p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT shpallelizabethj p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT champlinricharde p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules
AT anderssonborjes p1270myeloablativefractionatedbusulfanbasedconditioningregimeninpatientswithamlandmdsresultsofarandomizedclinicaltrialcomparing2fractionationschedules